Dark

ATXI
AVENUE THERAPEUTICS INC
stock OTC

EOD

Oct 1, 2026

0.3600USD-10.000%(-0.0400)20,613

Pre-market

0.00USD-100.000%(-0.40)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

739.41K

Headquarters

New York, USA

Industry

Biotechnology

Last Split

Apr 26, 20241for75reverse

OMER XLV

ATXI Stats

Avg. Vol. 10 Day

13,724

Avg. Vol. 30 Day

11,719

Market Cap

739,412

Shares Out.

2,053,923

6 Month Beta

-1.72

1 Year Beta

-1.02

2 Year Beta

0.07

3 Year Beta

0.18

52 Week Low

0.15

52 Week High

0.97

SMA50

0.40

SMA200

0.50

1 Week

-28.00%

1 Month

-36.84%

3 Month

+18.03%

6 Month

+2.86%

1 Year

-51.87%

2 Year

-85.12%

5 Year

-99.98%

Profile

avenue therapeutics, inc. (nasdaq: atxi), a fortress biotech (nasdaq: fbio) company, is a specialty pharmaceutical company focused on the development and commercialization of intravenous (iv) tramadol for the management of moderate to moderately severe postoperative pain. iv tramadol may fill a gap in the acute pain market between iv acetaminophen/nsaids and iv conventional narcotics. avenue is currently evaluating iv tramadol in a pivotal phase 3 program for the management of postoperative pain.

ATXI Stock Summary

AVENUE THERAPEUTICS INC (OTC:ATXI) stock price today is $0.3600, and today's volume is 20,613. ATXI is down -10.000% today. The 30 day average volume is 11,719. ATXI market cap is 739.41K with 2,053,923 shares outstanding.

document.getElementById("PMfxD3").onerror = function(){this.style.display='none';}; .dark-mode .Slq4yN{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .Slq4yN{ color: #333333; background-color: white; border: 2px solid #333333; }ATXIAVENUE THERAPEUTICS INCstock OTC

ATXI Stock Summary

ATXI
AVENUE THERAPEUTICS INC
stock OTC